Potential Areas of Interest in a Trial of Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin for Hepatocellular Carcinoma-In Reply.

JAMA Oncol

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.

Published: December 2019

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.4058DOI Listing

Publication Analysis

Top Keywords

potential areas
4
areas interest
4
interest trial
4
trial sorafenib
4
sorafenib hepatic
4
hepatic arterial
4
arterial infusion
4
infusion oxaliplatin
4
oxaliplatin fluorouracil
4
fluorouracil leucovorin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!